Legend Biotech (LEGN) Net Income (2019 - 2025)

Legend Biotech (LEGN) has reported Net Income for 7 consecutive years, with -$8.4 million the latest figure, recorded in Q4 2025.

• Net Income for Q4 2025 came in at -$8.4 million, down 115.36% year-over-year; the trailing twelve-month figure through Dec 2025 was -$277.4 million (down 259.69% YoY), and the FY2025 annual result was -$268.4 million, down 92.82% from the prior year.
• Net Income was -$8.4 million for Q4 2025 at Legend Biotech, up from -$38.5 million in the prior quarter.
• Over five years, Net Income peaked at $535.4 million in Q3 2022 and troughed at -$410.8 million in Q4 2021.
• Average Net Income over 5 years is -$53.1 million, with a median of -$84.5 million recorded in 2023.
• The widest YoY moves for Net Income: up 529.13% in 2022, down 32288.91% in 2022.
• Over 5 years, Net Income stood at -$410.8 million in 2021, then soared by 67.0% to -$135.6 million in 2022, then declined by 8.29% to -$146.8 million in 2023, then jumped by 137.26% to $54.7 million in 2024, then sank by 115.36% to -$8.4 million in 2025.
• Per Business Quant data, the three most recent Net Income figures were -$8.4 million in Q4 2025, -$38.5 million in Q3 2025, and -$124.2 million in Q2 2025.